The document discusses various treatment options for hepatic metastases from gastrointestinal carcinoid tumors. Supportive care and octreotide analogues are first-line treatments aimed at symptom control rather than increasing survival. Local hepatic therapies like chemoembolization and ablation can be tried if first-line treatments fail. Liver resection is the first choice for resection candidates but only 10% qualify. Liver transplantation is reserved for rare cases that are refractory to other options. Aggressive local and systemic therapies may increase 5-year survival to 50-70% compared to 0-40% with no treatment.